NeoGenomics Inc (NEO) stock
NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3023% below fair value
$15.25−0.16 (-1.04%)
Close on Nov 17, 2026Market cap $1.97BP/E –Yield –
NeoGenomics cash
Cash and short-term investments held at the end of each period.
NeoGenomics's cash was $139.28M at Sep 30, 2026. For fiscal 2025 it was $159.62M, down 56.5% from the year before. Over ten years it grew 21.2% a year on average. The highest annual figure on record is $515.39M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $159.62M | -56.5% |
| FY2024 | Dec 31, 2024 | $367.01M | +7.2% |
| FY2023 | Dec 31, 2023 | $342.49M | +30.1% |
| FY2022 | Dec 31, 2022 | $263.18M | -48.9% |
| FY2021 | Dec 31, 2021 | $515.39M | +62.0% |
| FY2020 | Dec 31, 2020 | $318.18M | +83.9% |
| FY2019 | Dec 31, 2019 | $173.02M | +1663.5% |
| FY2018 | Dec 31, 2018 | $9.81M | -23.5% |
| FY2017 | Dec 31, 2017 | $12.82M | +2.4% |
| FY2016 | Dec 31, 2016 | $12.53M | -46.5% |
| FY2015 | Dec 31, 2015 | $23.42M | -30.5% |
| FY2014 | Dec 31, 2014 | $33.69M | +596.9% |
| FY2013 | Dec 31, 2013 | $4.83M | +158.8% |
| FY2012 | Dec 31, 2012 | $1.87M | -28.9% |
| FY2011 | Dec 31, 2011 | $2.63M | +139.6% |
| FY2010 | Dec 31, 2010 | $1.10M | -32.7% |
| FY2009 | Dec 31, 2009 | $1.63M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $139.28M | -15.1% |
| Q2 FY2026 | Jun 30, 2026 | $145.54M | -5.9% |
| Q1 FY2026 | Mar 31, 2026 | $146.14M | -57.8% |
| Q4 FY2025 | Dec 31, 2025 | $159.62M | -56.5% |
| Q3 FY2025 | Sep 30, 2025 | $164.12M | -54.7% |
| Q2 FY2025 | Jun 30, 2025 | $154.72M | -56.4% |
| Q1 FY2025 | Mar 31, 2025 | $346.19M | +4.3% |
| Q4 FY2024 | Dec 31, 2024 | $367.01M | +7.2% |
| Q3 FY2024 | Sep 30, 2024 | $361.99M | +18.2% |
| Q2 FY2024 | Jun 30, 2024 | $355.09M | +22.8% |
| Q1 FY2024 | Mar 31, 2024 | $331.91M | +20.4% |
| Q4 FY2023 | Dec 31, 2023 | $342.49M | +30.1% |
| Q3 FY2023 | Sep 30, 2023 | $306.24M | +15.1% |
| Q2 FY2023 | Jun 30, 2023 | $289.07M | -38.0% |
| Q1 FY2023 | Mar 31, 2023 | $275.61M | -42.8% |
| Q4 FY2022 | Dec 31, 2022 | $263.18M | -48.9% |
| Q3 FY2022 | Sep 30, 2022 | $266.13M | -51.0% |
| Q2 FY2022 | Jun 30, 2022 | $465.95M | -18.5% |
| Q1 FY2022 | Mar 31, 2022 | $481.43M | -40.0% |
| Q4 FY2021 | Dec 31, 2021 | $515.39M | +62.0% |
| Q3 FY2021 | Sep 30, 2021 | $542.71M | +91.4% |
| Q2 FY2021 | Jun 30, 2021 | $571.75M | +93.6% |
| Q1 FY2021 | Mar 31, 2021 | $802.68M | +830.6% |
| Q4 FY2020 | Dec 31, 2020 | $318.18M | +83.9% |
| Q3 FY2020 | Sep 30, 2020 | $283.61M | +58.5% |
| Q2 FY2020 | Jun 30, 2020 | $295.28M | +76.4% |
| Q1 FY2020 | Mar 31, 2020 | $86.25M | +553.7% |
| Q4 FY2019 | Dec 31, 2019 | $173.02M | +1663.5% |
| Q3 FY2019 | Sep 30, 2019 | $178.89M | +51.0% |
| Q2 FY2019 | Jun 30, 2019 | $167.44M | +1674.6% |
| Q1 FY2019 | Mar 31, 2019 | $13.20M | -13.0% |
| Q4 FY2018 | Dec 31, 2018 | $9.81M | -23.5% |
| Q3 FY2018 | Sep 30, 2018 | $118.44M | +869.9% |
| Q2 FY2018 | Jun 30, 2018 | $9.44M | -13.7% |
| Q1 FY2018 | Mar 31, 2018 | $15.17M | +37.5% |
| Q4 FY2017 | Dec 31, 2017 | $12.82M | +2.4% |
| Q3 FY2017 | Sep 30, 2017 | $12.21M | – |
| Q2 FY2017 | Jun 30, 2017 | $10.93M | – |
| Q1 FY2017 | Mar 31, 2017 | $11.04M | – |
| Q4 FY2016 | Dec 31, 2016 | $12.53M | – |
See a number that looks wrong?